이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Delta 9 Cannabis 과거 수익 실적

과거 기준 확인 0/6

Delta 9 Cannabis의 수입은 연평균 -51.6%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 수입이 연평균 51%의 비율로 증가했습니다. 매출은 연평균 20.1%의 비율로 증가해 왔습니다.

주요 정보

-51.6%

수익 성장률

-45.6%

EPS 성장률

Pharmaceuticals 산업 성장	23.1%
매출 성장률	20.1%
자기자본 수익률	n/a
순이익	-27.7%
최근 수익 업데이트	31 Mar 2024

최근 과거 실적 업데이트

Recent updates

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

Jun 21

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

May 10

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Mar 26

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

Mar 26

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

Sep 09

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Jul 28

John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares

Dec 24

수익 및 비용 분석

Delta 9 Cannabis 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

TSX:DN 수익, 비용 및 수입 (CAD Millions )
날짜	수익	수익	G+A 비용
31 Mar 24	71	-20	28
31 Dec 23	71	-18	28
30 Sep 23	71	-22	30
30 Jun 23	68	-24	31
31 Mar 23	68	-26	32
31 Dec 22	63	-27	31
30 Sep 22	63	-21	29
30 Jun 22	62	-14	27
31 Mar 22	62	-11	26
31 Dec 21	62	-11	25
30 Sep 21	59	-8	24
30 Jun 21	57	-12	22
31 Mar 21	54	-13	22
31 Dec 20	52	-6	21
30 Sep 20	48	-8	18
30 Jun 20	42	-4	18
31 Mar 20	38	-3	17
31 Dec 19	32	11	17
30 Sep 19	26	12	19
30 Jun 19	21	11	19
31 Mar 19	13	10	17
31 Dec 18	8	-8	14
30 Sep 18	3	-12	10
30 Jun 18	2	-11	7
31 Mar 18	1	-9	5
31 Dec 17	1	-8	3
30 Sep 17	1	-2	2
30 Jun 17	1	-2	2
31 Mar 17	1	-1	2
31 Dec 16	0	-1	2
31 Dec 15	1	-1	1

양질의 수익: DN 은(는) 현재 수익성이 없습니다.

이익 마진 증가: DN 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: DN 은(는) 수익성이 없으며 지난 5년 동안 연간 51.6% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 DN 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: DN 은(는) 수익성이 없어 지난 해 수익 성장을 Pharmaceuticals 업계( 39.8% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: DN 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

Delta 9 Cannabis 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022)

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022)

Delta 9 Cannabis Inc. to Report Q3, 2023 Results on Nov 14, 2023

Second quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2022)

Delta 9 Cannabis Inc. to Report Q2, 2023 Results on Aug 14, 2023

Recent updates

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024

Co-Founder exercised options to buy CA$31k worth of stock.

Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022)

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

New major risk - Shareholder dilution

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022)

Delta 9 Cannabis Inc. to Report Q3, 2023 Results on Nov 14, 2023

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

New major risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2022)

New major risk - Share price stability

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Delta 9 Cannabis Inc. to Report Q2, 2023 Results on Aug 14, 2023

Co-Founder recently sold CA$99k worth of stock

First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.037 loss in 1Q 2022)

Delta 9 Cannabis Inc. to Report Q1, 2023 Results on May 15, 2023

Delta 9 Cannabis Inc. to Report Q4, 2022 Results on Mar 31, 2023

Co-Founder recently sold CA$52k worth of stock

Delta 9 Cannabis Inc. Announces Changes to Board of Directors

Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.011 loss in 3Q 2021)

Price target decreased to CA$0.80

Insufficient new directors

Delta 9 Cannabis Inc. Provides Earnings Guidance for the Quarter and Nine Months Ended September 30, 2022

Delta 9 Cannabis Inc. to Report Q3, 2022 Results on Nov 14, 2022

Delta 9 Cannabis Inc. (TSX:DN) acquired All or Substantially All Assets from 10552763 Canada Corp.

Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?

Price target decreased to CA$0.80

Second quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.014 loss in 2Q 2021)

Delta 9 Cannabis Inc. (TSX:DN) entered into an asset purchase agreement to acquire all or Substantially all assets of 10552763 Canada Corp. for CAD 3.25 million.

Joanne Duhoux-Defehr Resigns from Board of Directors of Delta 9 Cannabis Inc

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Price target decreased to CA$0.95

First quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.042 loss in 1Q 2021)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Months Period Ended March 31, 2022

Delta 9 Cannabis Inc., Annual General Meeting, Jun 29, 2022

Insufficient new directors

Full year 2021 earnings released: CA$0.11 loss per share (vs CA$0.072 loss in FY 2020)

Delta 9 Cannabis Inc. announced that it has received CAD 9.6 million in funding from Sundial Growers Inc.

Delta 9 Cannabis Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Year Ending December 31, 2021

Is Delta 9 Cannabis (TSE:DN) A Risky Investment?

Insufficient new directors

Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.07 loss in 3Q 2020)

Independent Director recently sold CA$126k worth of stock

Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt

Price target increased to CA$1.13

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 2Q 2020)

Delta 9 Cannabis Inc. Announces Health Canada Approval for Perimeter Expansion and Vault Area

Price target decreased to CA$1.04

Co-Founder exercised options to buy CA$63k worth of stock.

Co-Founder recently bought CA$53k worth of stock

Co-Founder recently bought CA$53k worth of stock

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three-Month and Six-Month Period Ending June 30, 2021

Co-Founder recently sold CA$138k worth of stock

Consensus revenue estimates fall to CA$66.3m

Co-Founder recently sold CA$115k worth of stock

First quarter 2021 earnings released: EPS CA$0.04 (vs CA$0.023 in 1Q 2020)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2021

Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt

Full year 2020 earnings released: CA$0.07 loss per share (vs CA$0.16 profit in FY 2019)

Delta 9 Cannabis Inc. Provides Update on Strategic Cooperation Agreement with F1NE Cannabis Cultivation LTD

Delta 9 Cannabis Inc. Launches Province Wide Delivery in Saskatchewan and Reserve Online in Alberta

Delta 9 Cannabis Inc. to Report Q4, 2020 Results on Mar 30, 2021

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

New 90-day low: CA$0.49